In conclusion, our study indicates that the detection of FDX1, DLAT, YY1 levels in the peripheral blood exosomes of patients with ovarian cancer can be used to quickly, accurately, and effectively predict the progress and prognosis of patients with ovarian cancer. Here, FDX1 is linked to ovarian cancer.